Moving forwards after disappointing data in the Huntington’s disease space Published 2022-09-30 Download video MP4 360p Download video MP4 720p Recommendations 04:47 What’s New in Huntington’s Disease 40:53 I have Huntington's Disease...My story 13:52 The latest long COVID research on symptoms, testing and treatments with Akiko Iwasaki, PhD 1:00:25 How do mitochondria contribute to health and disease? - Peter McGuire 03:21 Huntington's Disease: Can Gene Therapy Help? 12:41 Cervical Dystonia - Not gone with 510 Units of Botox! PNMD improved it in weeks. Migraines gone too! 02:19 Huntington's Disease Parity Act 01:23 What are the white spots on my MRI? 02:11 Emerging biomarkers of prognosis in MS 14:15 Киргизи та сирійці – остання надія Путіна – Яковина 05:54 The epidemiology of headaches in school-age children 02:52 Phase II trial of SAGE-718 for the treatment of cognitive impairment in Huntington’s disease 04:24 Ongoing trials with importance for Huntington’s disease 03:15 White matter lesions on your brain MRI? Here are the explanations. 49:55 💥ЧАЛИЙ: є ПОЗИТИВ у затягуванні допомоги США, ЄС за крок до рішення - правила голосування змінять 02:18 Predicting MS progression 00:31 What is Huntington disease? 30 Sec PSA 04:14 Update on huntingtin-lowering strategies under investigation for Huntington’s disease 39:50 HDSA RESEARCH WEBINAR: Update from PTC Therapeutics on the PIVOT-HD Trial 08:15 Wine Basics: Primary, Secondary and Tertiary Aromas and Flavors in Wine Similar videos 05:08 PTC518: oral splicing modifier under investigation for the treatment of Huntington’s disease 1:00:40 HDSA RESEARCH WEBINAR: HD Clinical Trial Update 01:02 New Huntington Disease Clinical Trial: PTC518 for Huntington Disease 43:44 Understanding Huntington Disease: The Importance of Observational Studies and How to Participate 1:02:47 Huntington's disease Clinical Trial Update 04:28 Driving progress in Huntington’s disease clinical research: patient education and engagement 58:15 An Update on HD Clinical Trials in Canada 02:20 ASO tominersen for Huntington’s disease in Phase III trials 1:00:28 Huntington disease (HD) Research Update 02:05 Tackling cognitive impairment in Huntington’s disease: a significant unmet need 02:31 NMDA receptor modulation as a novel therapeutic mechanism in Huntington’s disease 02:21 Huntingtin lowering: what level of wildtype protein knockdown is safe? 2:07:32 VIRTUAL ROUNDTABLE - Improving Access to Care for Huntington Families: What Role for Policymakers? 02:48 Edward Wild, MBBChir, PhD, MA: Generation HD1 Study of RG6042 1:08:57 RESEARCH WEBINAR: HDSA & the HD Research Pipeline 1:00:21 2022 Annual Huntington's Disease Symposium | Research Update 1:04:01 Breakthroughs in Disease Treatment: The Landscape Moving Forward More results